تخطَّ إلى المحتوى
دليل الأدوية المصري
تابع آخر تحديثات الأسعار على واتساب

سعر ريفابيوتك 300مجم 8 كبسول 2022

Rifabiotic 300 mg 8 caps

معلومات الدواء

التفاصيل الكاملة
دواعي الاستعمالUses
  • Treatment of all forms of tuberculosis, as part of a multidrug regimen (e.g. with isoniazid and pyrazinamide in the initial phase).DailyMed (U.S. National Library of Medicine)
  • Asymptomatic carriers of Neisseria meningitidis, to eliminate meningococci from the nasopharynx (not for treatment of meningococcal infection).DailyMed (U.S. National Library of Medicine)
  • Treatment of all forms of tuberculosis, as part of a multidrug regimen (e.g. with isoniazid and pyrazinamide in the initial phase).DailyMed (U.S. National Library of Medicine)
  • Asymptomatic carriers of Neisseria meningitidis, to eliminate meningococci from the nasopharynx (not for treatment of meningococcal infection).DailyMed (U.S. National Library of Medicine)
الآثار الجانبيةSide effects
  • Gastrointestinal effects (heartburn, epigastric distress, anorexia, nausea, vomiting, flatulence, cramps, diarrhoea); pseudomembranous colitis reported.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)
  • Hepatic (transient LFT abnormalities, hepatitis), haematologic (thrombocytopenia, leukopenia, haemolytic anaemia), CNS (headache, drowsiness, dizziness, fatigue), flushing/itching and hypersensitivity reactions.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)
  • Gastrointestinal effects (heartburn, epigastric distress, anorexia, nausea, vomiting, flatulence, cramps, diarrhoea); pseudomembranous colitis reported.International label, same formulation · DailyMed (U.S. National Library of Medicine)
  • Hepatic (transient LFT abnormalities, hepatitis), haematologic (thrombocytopenia, leukopenia, haemolytic anaemia), CNS (headache, drowsiness, dizziness, fatigue), flushing/itching and hypersensitivity reactions.International label, same formulation · DailyMed (U.S. National Library of Medicine)
موانع الاستعمالContraindications
  • Hypersensitivity to rifampin, any component, or any rifamycin.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)
  • Concomitant ritonavir-boosted saquinavir (severe hepatocellular toxicity).نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)
  • Concomitant atazanavir, darunavir, fosamprenavir, saquinavir, tipranavir, cabotegravir, fostemsavir or lenacapavir (loss of antiviral efficacy).نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)
عرض الكل (5)
  • Hypersensitivity to rifampin, any component, or any rifamycin.International label, same formulation · DailyMed (U.S. National Library of Medicine)
  • Concomitant ritonavir-boosted saquinavir (severe hepatocellular toxicity).International label, same formulation · DailyMed (U.S. National Library of Medicine)
  • Concomitant atazanavir, darunavir, fosamprenavir, saquinavir, tipranavir, cabotegravir, fostemsavir or lenacapavir (loss of antiviral efficacy).International label, same formulation · DailyMed (U.S. National Library of Medicine)
Show all (5)
تحذيرات واحتياطاتWarnings & precautions
  • Hepatotoxicity (hepatocellular, cholestatic or mixed), ranging up to fulminant liver failure and death; in hepatic impairment use only when necessary with liver monitoring every 2-4 weeks.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)
  • Systemic hypersensitivity reactions and severe cutaneous adverse reactions (SJS, TEN, AGEP, DRESS); discontinue if they occur.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)
  • Vitamin K-dependent coagulation disorders and bleeding; avoid high-dose cefazolin co-use in patients at bleeding risk.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)
عرض الكل (4)
  • Hepatotoxicity (hepatocellular, cholestatic or mixed), ranging up to fulminant liver failure and death; in hepatic impairment use only when necessary with liver monitoring every 2-4 weeks.International label, same formulation · DailyMed (U.S. National Library of Medicine)
  • Systemic hypersensitivity reactions and severe cutaneous adverse reactions (SJS, TEN, AGEP, DRESS); discontinue if they occur.International label, same formulation · DailyMed (U.S. National Library of Medicine)
  • Vitamin K-dependent coagulation disorders and bleeding; avoid high-dose cefazolin co-use in patients at bleeding risk.International label, same formulation · DailyMed (U.S. National Library of Medicine)
Show all (4)
التداخلات الدوائيةDrug interactions
  • Drugs metabolised by CYP1A2, 2B6, 2C8, 2C9, 2C19, 3A4, UGT or transported by P-gp/MRP2Rifampin induces these enzymes/transporters and may decrease concentrations and effect of many co-administered drugs; adjust doses per their labeling.DailyMed (U.S. National Library of Medicine)
  • Isoniazid / halothane / other hepatotoxic drugsIncreased potential for hepatotoxicity; avoid halothane and monitor closely with isoniazid.DailyMed (U.S. National Library of Medicine)
  • Drugs metabolised by CYP1A2, 2B6, 2C8, 2C9, 2C19, 3A4, UGT or transported by P-gp/MRP2Rifampin induces these enzymes/transporters and may decrease concentrations and effect of many co-administered drugs; adjust doses per their labeling.DailyMed (U.S. National Library of Medicine)
  • Isoniazid / halothane / other hepatotoxic drugsIncreased potential for hepatotoxicity; avoid halothane and monitor closely with isoniazid.DailyMed (U.S. National Library of Medicine)
الحمل والرضاعةPregnancy & breastfeeding
  • No adequate well-controlled studies in pregnant women; rifampin crosses the placenta; decades of data have not established an association with major birth defects; use only if benefit outweighs risk.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)
  • Because of tumorigenicity potential in animal studies, decide whether to discontinue nursing or the drug.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)
  • No adequate well-controlled studies in pregnant women; rifampin crosses the placenta; decades of data have not established an association with major birth defects; use only if benefit outweighs risk.International label, same formulation · DailyMed (U.S. National Library of Medicine)
  • Because of tumorigenicity potential in animal studies, decide whether to discontinue nursing or the drug.International label, same formulation · DailyMed (U.S. National Library of Medicine)
كيف يعمل الدواءHow it works
  • Inhibits bacterial DNA-dependent RNA polymerase (rifamycin antibiotic).
  • Rifampicin: Inhibits bacterial DNA-dependent RNA polymerase (rifamycin antibiotic).

المثائل (7)

كل المثائل والبدائل

نفس المادة الفعالة والتركيز. اسأل الصيدلي قبل الاستبدال.

مثائل ريفابيوتك 300مجم 8 كبسول بنفس المادة الفعالة والتركيز، مرتبة من الأرخص
ريفامبين 300مجم 10 كبسولRifampin 300mg 10 capsArab Caps · 300 mgالأرخصالسعر8ج.م0.8ج.م للوحدةالفرق عن الأصلينفس السعر
ريفامبيسين 300مجم 8 كبسولاتRifampicin 300mg 8 capsEl Nasr · 300 mgالسعر9.5ج.م1.19ج.م للوحدةالفرق عن الأصليأغلى 1.5ج.م (18.8%)
ريفامبين 300مجم 8 كبسولRifampin 300mg 8 caps (misr)Misr · 300 mgالسعر9.5ج.م1.19ج.م للوحدةالفرق عن الأصليأغلى 1.5ج.م (18.8%)
ريمكتان 300مجم 8 كبسولاتRimactane 300 mg capsulesNovartis · 300 mgالسعر10.1ج.م1.26ج.م للوحدةالفرق عن الأصليأغلى 2.1ج.م (26.2%)
ريمكتان 300مجم 8 كبسولاتRimactane 300 mg capsulesNovartis · 300 mgالسعر10.1ج.م1.26ج.م للوحدةالفرق عن الأصليأغلى 2.1ج.م (26.2%)

أدوية ذات صلة

نفس المادة الفعالة بتركيز آخر

منتجات أخرى من CID

من فئة مضاد حيوي

المصادر

تعليقات

لا توجد تعليقات بعد. كن أول من يشارك تجربته مع هذا الدواء.

أضف تعليقًا

0/60

لا يُنشر أبدًا؛ للتواصل فقط إن لزم.

0/1000

من 20 إلى 1000 حرف. بدون روابط.

التعليقات للمعلومات العامة ولا تُعد نصيحة طبية. لا تذكر بيانات شخصية.